Patents by Inventor Sajiv Nair

Sajiv Nair has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel compounds of amino sulfonyl derivatives
    Publication number: 20070027118
    Abstract: The present invention relates to compounds with formula (I) or a pharmaceutically acceptable salt thereof: wherein; T is a (4 to 10)-membered heterocyclyl and wherein R1, R2 and R3 are as defined in the specification. The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating a condition that is mediated by the modulation of the 11-?-hsd-1 enzyme.
    Type: Application
    Filed: April 6, 2006
    Publication date: February 1, 2007
    Inventors: Hengmiao Cheng, Stephan Cripps, Klaus Dress, Buwen Huang, Sajiv Nair, Yong Wang
  • Novel compounds of proline and morpholine derivatives
    Publication number: 20050261290
    Abstract: The present invention relates to compounds with the formulas (I), (II), and (III), or a pharmaceutically acceptable salt thereof: wherein T is a (4 to 10)-membered heterocyclyl selected from the group consisting of and wherein R1, R2 and R3 are as defined in the specification. The invention also relates to pharmaceutical compositions comprising the compounds of formulas (I), (II), and (III) and methods of treating a condition that is mediated by the modulation of the 11-?-hsd-1 enzyme, the method comprising administering to a mammal an effective amount of a compound of formulas (I), (II), and (III).
    Type: Application
    Filed: May 4, 2005
    Publication date: November 24, 2005
    Inventors: Hengmiao Cheng, Stephan Cripps, Klaus Dress, Jacqui Hoffman, Buwen Huang, Stanley Kupchinsky, Phuong Le, Sajiv Nair, Timothy Parrott, Christopher Smith, Yong Wang, Yi Yang
  • Amino heterocyclyl inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
    Publication number: 20050148631
    Abstract: The present invention relates to compounds with the formula (I), or a pharmaceutically acceptable salt thereof: The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) or formula (II) and methods of treating a condition that is mediated by the modulation of 11-?-hsd-1, the method comprising administering to a mammal an effective amount of a compound of formula (I) or formula (II).
    Type: Application
    Filed: December 17, 2004
    Publication date: July 7, 2005
    Inventors: Hengmiao Cheng, Stephan Cripps, Martin Edwards, Theodore Johnson, Sajiv Nair, Michael Siu, Christopher Smith, Wendy Taylor, Yong Wang